Use of combination evidence-based medical therapy prior to acute myocardial infarction (from the National Registry of Myocardial Infarction-4)

American Journal of Cardiology

Volumn 96, Issue 7, 2005, Pages 922-926

  Spencer, Frederick A ^a   Frederick, Paul D ^b   Goldberg, Robert J ^a   Gore, Joel M ^a   Tiefenbrunn, Alan J ^c  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b Ovation Research Group   (United States)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LIPID;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DEMOGRAPHY; DIABETES MELLITUS; EVIDENCE BASED MEDICINE; FEMALE; FOLLOW UP; HEALTH INSURANCE; HOSPITAL ADMISSION; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MEDICARE; PRIORITY JOURNAL; REGISTER; SEX DIFFERENCE; UNITED STATES;

ADRENERGIC BETA-ANTAGONISTS; AGED; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ASPIRIN; CORONARY ARTERIOSCLEROSIS; CROSS-SECTIONAL STUDIES; DRUG THERAPY, COMBINATION; EVIDENCE-BASED MEDICINE; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION;

EID: 25444486131     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2005.05.048     Document Type: Article

References (11)

1. W.J. Rogers, L.J. Bowlby, N.C. Chandra, W.J. French, J.M. Gore, C.T. Lambrew, R.M. Rubison, A.J. Tiefenbrunn, W.D. Weaver Treatment of myocardial infarction in the United States (1990 to 1993) observations from the National Registry of Myocardial Infarction Circulation 90 1994 2103 2114
2. W.J. Rogers, J.G. Canto, C.T. Lambrew, A.J. Tiefenbrunn, B. Kinkaid, D.A. Shoultz, P.D. Frederick, N. Every Temporal trends in the treatment of over 1.5 million patients with myocardial infarction in the U.S. from 1990 through 1999 the National Registry of Myocardial Infarction 1, 2 and 3 J Am Coll Cardiol 36 2000 2056 2063
3. Anti-platelet Trialists Collaboration Secondary prevention of vascular disease by prolonged antiplatelet therapy BMJ 296 1988 320 331
4. K.K. Teo, S. Yusuf, C.D. Furberg Effects of prophylactic antiarrhythmic drug therapy in acute myocardial infarction JAMA 270 1993 1589 1595
5. ACE Inhibitor Myocardial Infarction Collaborative Group Indications for ACE inhibitors in the early treatment of acute myocardial infarction systematic overview of individual data from 100,000 patients in randomized clinical trials Circulation 97 1998 2202 2212
6. The Heart Outcomes Prevention Evaluation Study Investigators Effects of an ACE-inhibitor, ramipril, on cardiovascular events in high-risk patients N Engl J Med 342 2000 145 153
7. F.M. Sacks, M.A. Pfeffer, L.A. Moye, J.L. Rouleau, J.D. Rutherford, T.G. Cole, L. Brown, J.W. Warnica, J.M. Arnold, C.C. Wun, B.R. Davis, E. Braunwald Cholesterol and Recurrent Events Trial Investigators The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels N Engl J Med 335 1996 1001 1009
8. The Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels N Engl J Med 339 1998 1349 1357
9. Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease the Scandinavian Simvastatin Survival Study (4S) Lancet 344 1994 1383 1389
10. S. Yusuf Two decades of progress in preventing vascular disease Lancet 360 2002 2 3
11. D. Mukherjee, J. Fang, S. Chetcuti, M. Moscucci, E. Kline-Rogers, K.A. Eagle Impact of combination evidence-based medical therapy on mortality in patients with acute coronary syndromes Circulation 109 2004 745 749